Multiple Myeloma Resource Center

Several Risk Factors of Osteonecrosis of Femoral Head in Patients with MM Undergoing Dexamethasone-Based...

A study published in BioMed Research International identified several risk factors for osteonecrosis of femoral head (ONFH) in patients with multiple myeloma (MM) undergoing...

For Patients with Multiple Myeloma, Preferred Treatments Vary

Not all people living with multiple myeloma (MM) value the same treatment attributes equally, according to a study published in BMC Cancer.   Investigators collated data...

Identifying Racial Disparities in Multiple Myeloma Treatment

Structural barriers in the medical system along with logistical issues may be the root of racial disparities of novel agents for the frontline treatment...

Novel Agents Significantly Improve Mortality Rates for Patients with Multiple Myeloma

A study which appeared in the International Journal of Cancer shows that novel agents for multiple myeloma significantly improve mortality rates and may encourage...

Literature Review: Examining the Connection Between Synchronous Multiple Myeloma and Other Primary Malignant Tumors

There exists a mystery connection between synchronous multiple myeloma (MM) and other primary malignant tumors (PMTs), according to the findings of a study published...

Patients with Smoldering Multiple Myeloma and Multiple Myeloma are Vulnerable to Various Components of...

Patients with smoldering multiple myeloma (SMM) and those with multiple myeloma (MM) are more prone to developing different components of metabolic syndrome, according to...

Palliative Radiation Therapy Benefits Patients with Multiple Myeloma

Palliative radiation therapy (RT) is associated with reduced multiple myeloma (MM) symptoms compared to nonuse, according to a study published in the Swedish journal...

Journal Reading List

Advertisement
Advertisement